Narrow Band Imaging (NBI) Against Lugol for Squamous Esophageal Cancer

NCT02002559 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2019-07-23

No results posted yet for this study

Summary

This study aimed to compare Narrow Band Imaging (NBI) against Lugol chromoendoscopy for diagnosis of early esophageal cancers among high risk patients.

Conditions

  • Superficial Esophageal Neoplasia

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Philip WY Chiu, MD · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02002559 on ClinicalTrials.gov